Klisic, A. (2024) “Serum galectin-3 and fibroblast growth factor-23 levels in relation with type 2 diabetes and cardiovascular risk : Galectin-3 and FGF-23 in relation to diabetes and CV risk”, Journal of Medical Biochemistry, 44(1), pp. 85–92. doi:10.5937/jomb0-50471.